SCHEMBL846923

SCHEMBL846923

Nc1nc(N)c(-c2ccc3[nH]ccc3c2)c(-c2ccc3[nH]ccc3c2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.47
NPC1 O15118 1/20 0.46
ADORA2A P29274 2/20 0.45
ADORA1 P30542 2/20 0.45
PIK3CD O00329 2/20 0.44
ABL1 P00519 2/20 0.44
EGFR P00533 2/20 0.44
HCK P08631 2/20 0.44
SRC P12931 2/20 0.44
KDR P35968 2/20 0.44
PIK3CA P42336 2/20 0.44
PIK3CB P42338 2/20 0.44
MTOR P42345 2/20 0.44
PIK3CG P48736 2/20 0.44
EPHB4 P54760 2/20 0.44
PRKDC P78527 2/20 0.44
PI4KB Q9UBF8 2/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27612533 0.84 PIK3CD (0.46) BRD4NPC1ADORA2AADORA1PIK3CD
SCHEMBL6361280 0.80 HEXA (0.57) MEN1KMT2ACYP3A4CYP2D6
SCHEMBL847565 0.77 CYP2A6 (0.49) ABL1EGFRKDR
SCHEMBL1640616 0.74 BRAF (0.58) NPC1ADORA2AADORA1PIK3CDABL1
SCHEMBL2745043 0.73 DHFR (0.59) NPC1CYP3A4CYP2D6MAP3K11LRRK2
SCHEMBL5850255 0.72 NPC1 (0.79) BRD4NPC1CA12CA1CA2
SCHEMBL4265699 0.72 PIK3CD (0.52) PIK3CDABL1EGFRHCKSRC
SCHEMBL27631876 0.72 ADORA2A (0.56) BRD4ADORA2AADORA1PIK3CDABL1
SCHEMBL4737438 0.71 TYMS (0.47) NPC1ADORA2AADORA1PIK3CDABL1
SCHEMBL3364409 0.71 HSP90AA1 (0.54) BRD4NPC1ADORA2AADORA1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2433636-A1 Treatment of Malignant Diseases Medizinische Universität Wien (AT) 2012-03-28 EP claimed
EP-2433636-A1 Treatment of Malignant Diseases Medizinische Universität Wien (AT) 2012-03-28 EP disclosed
EP-2433636-A1 Treatment of Malignant Diseases Medizinische Universität Wien (AT) 2012-03-28 EP disclosed